CLINICAL_TRIALS
trial_result
· 2016-04-07
Clinical Trial Update: LEA29Y (Belatacept) Emory Edmonton Protocol [Phase 2]
Summary
A Phase 2 clinical trial update for belatacept (LEA29Y) under the Emory Edmonton protocol for Type 1 Diabetes Mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED